The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.

The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.

We recently compiled a list of the 10 Best Fortune 500 Stocks To Buy Now. In this article, we are going to take a look at ...

Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.

The Federal Trade Commission has brought an administrative complaint against three of the country's largest pharmacy benefit ...

The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

This week's dividend activity included increased payouts from Microsoft (NASDAQ:MSFT) and JPMorgan (NYSE:JPM) as well as ...

CVS Health ( NYSE: CVS) subsidiary Oak Street Health has reached a $60M settlement with the Department of Justice to resolve ...

CVS Health Corp. closed $24.83 short of its 52-week high ($83.25), which the company reached on January 8th.

The owner of one of the three largest pharmacy middlemen in the United States on Tuesday filed suit to quash an attempt by ...

The FTC sued UnitedHealth Group’s Optum unit, CVS Caremark and Cigna’s Express Scripts for allegedly steering diabetes ...